Jallad RS - Search Results

1

[Recommendations of Neuroendocrinology Department from Brazilian Society of Endocrinology and Metabolism for diagnosis and treatment of acromegaly in Brazil].

Vieira Neto L, Abucham J, Araujo LA, Boguszewski CL, Bronstein MD, Czepielewski M, Jallad RS, Musolino NR, Naves LA, Ribeiro-Oliveira Júnior A, Vilar L, Faria Mdos S, Gadelha MR. Vieira Neto L, et al. Among authors: jallad rs. Arq Bras Endocrinol Metabol. 2011 Mar;55(2):91-105. doi: 10.1590/S0004-27302011000200001. Arq Bras Endocrinol Metabol. 2011. PMID: 21584426 Review. Portuguese.

2

Treatment of acromegaly with octreotide-LAR: extensive experience in a Brazilian institution.

Jallad RS, Musolino NR, Salgado LR, Bronstein MD. Jallad RS, et al. Clin Endocrinol (Oxf). 2005 Aug;63(2):168-75. doi: 10.1111/j.1365-2265.2005.02317.x. Clin Endocrinol (Oxf). 2005. PMID: 16060910

3

Pharmacokinetic profile of lanreotide Autogel in patients with acromegaly after four deep subcutaneous injections of 60, 90 or 120 mg every 28 days.

Bronstein M, Musolino N, Jallad R, Cendros JM, Ramis J, Obach R, Leselbaum A, Catus F. Bronstein M, et al. Clin Endocrinol (Oxf). 2005 Nov;63(5):514-9. doi: 10.1111/j.1365-2265.2005.02372.x. Clin Endocrinol (Oxf). 2005. PMID: 16268802 Clinical Trial.

4

Dissociation between tumor shrinkage and hormonal response during somatostatin analog treatment in an acromegalic patient: preferential expression of somatostatin receptor subtype 3.

Casarini AP, Pinto EM, Jallad RS, Giorgi RR, Giannella-Neto D, Bronstein MD. Casarini AP, et al. Among authors: jallad rs. J Endocrinol Invest. 2006 Oct;29(9):826-30. doi: 10.1007/BF03347378. J Endocrinol Invest. 2006. PMID: 17114915

5

Treatment of acromegaly: is there still a place for radiotherapy?

Jallad RS, Musolino NR, Salgado LR, Bronstein MD. Jallad RS, et al. Pituitary. 2007;10(1):53-9. doi: 10.1007/s11102-007-0002-5. Pituitary. 2007. PMID: 17318438

6

Does partial surgical tumour removal influence the response to octreotide-LAR in acromegalic patients previously resistant to the somatostatin analogue?

Jallad RS, Musolino NR, Kodaira S, Cescato VA, Bronstein MD. Jallad RS, et al. Clin Endocrinol (Oxf). 2007 Aug;67(2):310-5. doi: 10.1111/j.1365-2265.2007.02885.x. Epub 2007 Jun 6. Clin Endocrinol (Oxf). 2007. PMID: 17555503

7

[Growth hormone deficiency in adulthood: how to diagnose and when to treat?].

Jallad RS, Bronstein MD. Jallad RS, et al. Arq Bras Endocrinol Metabol. 2008 Jul;52(5):861-71. doi: 10.1590/s0004-27302008000500019. Arq Bras Endocrinol Metabol. 2008. PMID: 18797594 Review. Portuguese.

8

Acromegaly: correlation between expression of somatostatin receptor subtypes and response to octreotide-lar treatment.

Casarini AP, Jallad RS, Pinto EM, Soares IC, Nonogaki S, Giannella-Neto D, Musolino NR, Alves VA, Bronstein MD. Casarini AP, et al. Among authors: jallad rs. Pituitary. 2009;12(4):297-303. doi: 10.1007/s11102-009-0175-1. Pituitary. 2009. PMID: 19330452

9

Optimizing medical therapy of acromegaly: beneficial effects of cabergoline in patients uncontrolled with long-acting release octreotide.

Jallad RS, Bronstein MD. Jallad RS, et al. Neuroendocrinology. 2009;90(1):82-92. doi: 10.1159/000218323. Epub 2009 May 8. Neuroendocrinology. 2009. PMID: 19439914 Clinical Trial.

10

[TSH-secreting pituitary tumors: two case reports and literature review].

Duarte FH, Jallad RS, Salgado LR, Bronstein MD. Duarte FH, et al. Among authors: jallad rs. Arq Bras Endocrinol Metabol. 2009 Dec;53(9):1157-66. doi: 10.1590/s0004-27302009000900013. Arq Bras Endocrinol Metabol. 2009. PMID: 20126874 Review. Portuguese.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

42 results

Search Page

Filters